Niki Biosolutions, Inc. (NIKI) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Niki Biosolutions, Inc. (NIKI) stock forecast summary
Our AI ranks Niki Biosolutions, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Niki Biosolutions, Inc. is a small-cap company with a market capitalization of $6M. It ranks number 11 by market capitalization among the 11 Measuring & Controlling Devices, NEC issuers in our coverage with a current forecast. Its P/B Ratio of 0.26x is the lowest of the 11 peers that report one.
For NIKI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 2.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, NIKI included.
Follow NIKI freeNIKI price chart and AI forecast
How NIKI ranks among 5184 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Niki Biosolutions, Inc. (NIKI) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Measuring & Controlling Devices, NEC peers listed below that report each metric.
Valuation & Market
| Metric | NIKI | Rank |
|---|---|---|
| Market Cap | $6M | 11/11 |
| P/B Ratio | 0.26x | 11/11 |
| Book Value/Share | $7.86 | – |
Financial Health
| Metric | NIKI | Rank |
|---|---|---|
| D/E Ratio | 0.21x | 9/11 |
| Financial Leverage | 0.81x | 11/11 |
Dividend & Shareholder Information
| Metric | NIKI | Rank |
|---|---|---|
| Shares Outstanding | 3M | – |
Balance Sheet Highlights (USD millions)
| Accounts Receivable | $110K | 0.4% of assets |
| Total Liabilities | $5M | 17.6% of assets |
NIKI quarterly financials and insider trading
Niki Biosolutions, Inc. (NIKI) industry peers
Companies classified under the same SEC industry code as Niki Biosolutions, Inc. (Measuring & Controlling Devices, NEC): 11 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| NIKI Niki Biosolutions, Inc. | ▲ | $6M |
| TMO Thermo Fisher Scientific Inc. | ▼ | $255.13B |
| ROK Rockwell Automation, Inc | ▼ | $47.33B |
| TRMB Trimble Inc. | ▶ | $13.86B |
| ONTO Onto Innovation Inc. | ▲ | $10.83B |
| MIR Mirion Technologies, Inc. | ▶ | $3.47B |
| QSI Quantum-Si Inc | ▲ | $241M |
| OWLT Owlet, Inc. | ▲ | $120M |
| GEOS Geospace Technologies Corp | ▶ | $57M |
| AATC Autoscope Technologies Corp | ▼ | $32M |
| BCHT Birchtech Corp. | ▲ | $31M |
Where NIKI sits on the market map
Niki Biosolutions, Inc. (NIKI) stock news
Loading...
Niki Biosolutions, Inc. (NIKI) stock forecast FAQ
What is the Niki Biosolutions, Inc. (NIKI) stock forecast?
Our AI ranks Niki Biosolutions, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Niki Biosolutions, Inc. stock predictions?
For NIKI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 2.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 8.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Niki Biosolutions, Inc. forecasts updated?
Niki Biosolutions, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Niki Biosolutions, Inc.'s industry peers?
11 issuers in our coverage, NIKI included, share the SEC industry code Measuring & Controlling Devices, NEC. The largest are: Thermo Fisher Scientific Inc. (TMO), Rockwell Automation, Inc (ROK), Trimble Inc. (TRMB), Onto Innovation Inc. (ONTO), Mirion Technologies, Inc. (MIR), Quantum-Si Inc (QSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.